Lymphoma Patients' quality of life under the microscope in new CAR-T study
NCT ID NCT04914091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 70 adults with diffuse large B-cell lymphoma who are receiving CAR-T cell therapy outside of a clinical trial. Researchers will track patients' quality of life, medication use, and personal feedback over time using questionnaires. The goal is to understand the real-world impact of this expensive, innovative treatment on daily living.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CART-CELLS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique
RECRUITINGPierre-Bénite, 69495, France